Suchergebnisse - RERO DOC

Consortium of Swiss Academic Libraries

Quality of analgesic treatment in patients with advanced prostate cancer: do we do a better job now? The Swiss Group for Clinical Cancer Research (SAKK) experience

Münger-Beyeler, C. ; Bernhard, J. ; Rufibach, K. ; Morant, R. ; Schmid, H.-P

In: Supportive Care in Cancer, 2008, vol. 16, no. 5, p. 461-467

Consortium of Swiss Academic Libraries

5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere®)-cisplatin in advanced gastric carcinoma: a phase I-II trial

Roth, A. D. ; Maibach, R. ; Fazio, N. ; Sessa, C. ; Stupp, R. ; Morant, R. ; Herrmann, R. ; Borner, M. M. ; Goldhirsch, A. ; de Braud, F.

In: Annals of Oncology, 2004, vol. 15, no. 5, p. 759-764

Consortium of Swiss Academic Libraries

Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study

Seium, Y. ; Stupp, R. ; Ruhstaller, T. ; Gervaz, P. ; Mentha, G. ; Philippe, M. ; Allal, A. ; Trembleau, C. ; Bauer, J. ; Morant, R. ; Roth, A. D.

In: Annals of Oncology, 2005, vol. 16, no. 5, p. 762-766

Consortium of Swiss Academic Libraries

Docetaxel (Taxotere®)-cisplatin (TC): An effective drug combination in gastric carcinoma

Roth, A. D. ; Maibach, R. ; Martinelli, G. ; Fazio, N. ; Aapro, M. S. ; Pagani, O. ; Morant, R. ; Borner, M. M. ; Herrmann, R. ; Honegger, H. ; Cavalli, F. ; Alberto, P. ; Castiglione, M. ; Goldhirsch, A.

In: Annals of Oncology, 2000, vol. 11, no. 3, p. 301-306

Consortium of Swiss Academic Libraries

The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: Results of a phase III trial

Borner, M. M. ; Castiglione, M. ; Bacchi, M. ; Weber, W. ; Herrmann, R. ; Fey, M. F. ; Pagani, O. ; Leyvraz, S. ; Morant, R. ; Pestalozzi, B. ; Hanselmann, S. ; Goldhirsch, A.

In: Annals of Oncology, 1998, vol. 9, no. 5, p. 535-541

Powered by Invenio
/ © Copyright RERO